What the buyer wrote
DNA sequencing instrument to deliver a flexible and cost-effective service to researchers in the University, NHS and other external collaborators and customers. This instrument is required to fulfil the role currently served by our Illumina HiSeq 2500 and is complementary to our other sequencing instruments including an Illumina MiSeq, a Pacific Biosciences Sequel, Oxford Nanopore MinIONs. While those complementary instruments provide longer reads useful for de novo assembly, the main functionalities required of the new instrument are high throughput, high accuracy and low cost per megabase of sequence data, and ability to sequence small quantities of DNA sample (nanomoles or less). The main…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- DNA Sequencer
- How they are buying
- Called off an existing agreementThe work went to a supplier already on a framework or dynamic market.
- Type
- goods
- Work starts
- 20 Jun 2019
- Work ends
- 20 Jun 2020
Who the buyer named
The buyer published a contact address on this notice.